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INTRODUCTION
Arthritis is not a disease by itself but it is a manifestation of internal disease. 
Juvenile  idiopathic  arthritis  is  the  most  common  cause  of  chronic  arthritis  in 
childhood.  It  is  a  heterogenous  disease  with  three  onset  types  –  ligoarticular, 
polyarticular, systemic onset. The major morbidity is related to chronic synovitis, joint 
destruction  and  drug  toxicity.  A better  understanding  of  clinical  and  immunological 
profile will result in early diagnosis, prompt treatment and reduction in morbidity
ETIOLOGY. (3),(8)
The etiology of this type of chronic arthritis in children is unknown. At least two 
necessary  events  are  postulated:  immunogenetic  susceptibility  and  an  external, 
presumably  environmental,  trigger.  Specific  HLA  subtypes  confer  degrees  of 
susceptibility, or indeed protection, depending on the age of the child. Possible external 
triggers  include  viruses  (parvovirus  B19,  rubella,  Epstein-Barr  virus),  host 
hyperreactivity to specific self antigens (type II collagen), and enhanced T-cell reactivity 
to bacterial or mycobacterial heat shock proteins.
EPIDEMIOLOGY. (8)
The incidence of JRA is ≈13.9/100,000 children/yr among white children ≤15 yr 
of age, with a prevalence of ≈113/100,000 children. A report from western Australia, (7) 
estimates a much higher prevalence of 400/100,000 based  on sequential examinations 
of school children by a pediatric rheumatologist. A report from UK , incidence in west 6-
8 cases/100000.(23) 
Different racial and ethnic groups have varying frequencies of the subtypes  of 
JRA. African-American children may be older at onset and less likely to have elevated 
antinuclear antibody (ANA) titers or develop chronic uveitis
 Pathogenesis and Etiology of JRA: Multi-factorial
• Genetic, Hormonal, Immunologic
• Pathogenesis
 Characterized by chronic inflammation of the synovium;
 Presence  of articular cartilage damage;
 Accompanied by extra-articular systemic manifestations. 
• Heterogeneity of JRA
 At least 3 primary types of onset of JRA: 
• Pauciarticular (Oligoarticular) 
• Polyarticular and 
• Systemic
• Genetic
 Basis of immune distinction between self and non-self is 
 the major histocompatibility complex (MHC) that in 
 humans is called the human leukocyte antigen (HLA). 
 HLA system comprises a family of polymorphic genes 
 located on the short arm of chromosome 6.
 Polymorphisms of JRA suggest a non-mendelian inheritance. 
• Hormonal Factors
 Differences in the sex ratio of JRA subtype onset
 Pre-adolescent or post-adolescent peaks
 Immune Mechanisms
• Disease process involves loss of tolerance towards auto-
• antigens → chronic synovitis;
• Production of auto-antibodies:
 Anti-nuclear  antibodies  (ANA):  associated  with  increased  risk  of 
iridocyclitis (eye inflammation);
 Rheumatoid  factors  (RF):  auto-antibodies  directed  against  the  Fc 
fragment of IgG (associated with ~10% of polyarticular JRA);
 Complement activation by circulating immune complexes may also 
contribute to the disease process.
• Immune Mechanisms 
• Cytokines: act on the immune system and other cells to initiate  and sustain 
inflammation:
• Intercellular mediators: Interleukin-1 (IL-1), IL-6, and tumor 
necrosis factor-alpha (TNF-∝);
• Immunomodulatory  cytokines  produced  by  T-cells  → 
Interferon gamma (IFN-γ), IL-4, IL-2.
CLASSIFICATION OF JRA 
 ACR Criteria (1) ,(6)
• Age at onset: < 16 years of age;
• Arthritis - swelling or effusion or the presence of 2 or more of the following 
signs: 
 Limitation of range of motion, 
 Tenderness or pain on motion and
  Increased heat in one or more joints;
• Duration of disease > 6 weeks;
• Onset type is defined by the type of disease in the first 6months:
 Oligoarticular (Pauciarticular) < 5 inflamed joints;
 Polyarticular: > 5 inflamed joints;
 Systemic onset: arthritis with characteristic fever.
• Exclusion of other forms of childhood arthritis.
To classify these patients in well-defined diagnostic categories, a task force of the 
International League against  Rheumatism (ILAR) proposed a new classification with 
precise criteria with the aim of achieving as much homogeneity within categories as 
possible in order to facilitate communication, clinical research and patient care.
The  International   League   of   Associations   for  Rheumatology  (ILAR) 
classification of  juvenile  idiopathic arthritis (JIA) recognizes 8 categories(4), (5) :
1. Systemic  arthritis, 
2. Oligoarthritis ,
3. Extended  oligoarthritis,
4. Polyarthritis   [rheumatoid factor (RF) positive],
5. Polyarthritis (RF negative), 
6. Enthesitis  related arthritis,
7. Psoriatic  arthritis,
8. and “other arthritis.” 
General Definition of JIA
Juvenile idiopathic arthritis is arthritis of unknown etiology that begins before the 
16th birthday and persists for at least 6 weeks; other known conditions are excluded.
Exclusions
The  principle  of  this  classification  is that all categories of  JIA are mutually 
exclusive. This  principle is reflected in the list of possible  exclusions for each category:
a. Psoriasis or a history of psoriasis in the patient or first degree relative.
b. Arthritis in an HLA-B27 positive male beginning after the 6th birthday.
c. Ankylosing spondylitis, enthesitis related arthritis, sacroiliitis with inflammatory 
bowel disease, Reiters syndrome, or acute anterior uveitis,  or a history of one of 
these disorders in a first-degree relative.
d. The presence of IgM rheumatoid factor on at least 2 occasions at least 3 months 
apart.
e. The presence of systemic JIA in the patient.
The application of exclusions is indicated under each category, and may change as 
new data become available
Categories
Systemic Arthritis
Definition: Arthritis in one or more joints with or preceded by fever of at least 2 
weeks’ duration that is documented to be daily (“quotidian”) for at least 3 days, and 
accompanied by one or more of the following:
1. Evanescent (nonfixed) erythematous rash
2. Generalized lymph node enlargement
3. Hepatomegaly and/or splenomegaly
4. Serositis 
Exclusions: a, b, c, d.
Oligoarthritis
Definition: Arthritis affecting one to 4 joints during the first 6 months of  disease. 
Two subcategories are recognize
1. Persistent oligoarthritis: Affecting not more than 4 joints throughout  the  disease 
course
2. Extended oligoarthritis: Affecting a total of more than 4 joints after the first  6 
months of disease
Exclusions: a, b, c, d, e.
Polyarthritis (Rheumatoid Factor Negative)
Definition:  Arthritis  affecting  5  or  more  joints  during  the  first  6  months  of 
disease; a test for RF is negative.
Exclusions: a, b, c, d, e.
Polyarthritis (Rheumatoid Factor Positive)
Definition:  Arthritis  affecting  5  or  more  joints  during  the  first  6  months  of 
disease; 2 or more tests for  RF at least  3 months apart during the first  6 months of 
disease are positive.
Exclusions: a, b, c, e.
CLINICAL MANIFESTATIONS. 
Initial symptoms may be subtle or acute, and often include morning stiffness and 
gelling, easy fatigability, particularly after school in the early afternoon, joint pain later 
in the day, and objective joint swelling. The involved joints are often warm, resist full 
range of motion, are painful on motion, but are not usually erythematous.
Oligoarthritis (pauciarticular disease) predominantly affects the joints of the 
lower extremities, such as the knees and ankles . Often,  only a single joint is involved at 
onset. Isolated involvement of upper extremity large joints is not characteristic of this 
type of onset. Involvement of the hip is almost never a presenting sign of JRA. Hip 
disease may occur later, particularly in polyarticular JRA, and is often a component of a 
deteriorating functional course 
Polyarthritis (polyarticular disease) is generally characterized by involvement 
of both large and small joints of both upper and lower extremities. As many as 20–40 
joints may be  affected in the more severely involved child, although inflammation of 
only   ≥5  joints  is  required  as  a  criterion  for  classification  of  this  type  of  onset. 
Polyarticular disease may resemble the characteristic presentation of adult  rheumatoid 
arthritis and the HLA profile is often similar.  Rheumatoid   nodules on the extensor 
surfaces of the elbows and over the Achilles  tendons, while unusual, are associated with 
a more severe course.  Micrognathia reflects chronic temporo mandibular joint disease. 
Cervical  spine involvement of the apophyseal joints  occurs frequently  with a risk of 
atlantoaxial subluxation and potential  neurologic sequelae.
Systemic-onset  disease is  characterized  by  arthritis  and  prominent  visceral 
involvement that includes hepatosplenomegaly, lymphadenopathy, and serositis, such as 
a  pericardial  effusion.  It  is  characterized  by  a  quotidian  fever  with  temperatures  to 
≥39°C, sometimes followed by mildly hypothermic temperatures for ≥2 wk. Each febrile 
episode is frequently accompanied by a characteristic faint, erythematous, macular rash; 
these evanescent  salmon-colored lesions may be linear or circular,  from 2–5 mm in 
size, and are often distributed in groups with a linear distribution most commonly over 
the trunk and proximal extremities . This rash is not pruritic. Its most diagnostic feature 
is  its  transient  nature,  with  a  group  of  lesions  usually  lasting  <1  hr.  The  Koebner 
phenomenon, which is cutaneous hypersensitivity to superficial trauma resulting in a 
localized recurrence  of  the rash,  is  suggestive,  but  not  diagnostic,  of  systemic-onset 
disease. Heat, such as a warm bath, also evokes a reappearance of the rash.
DIAGNOSIS
The  diagnosis  is  greatly  aided  by  the  ACR  Classification  Criteria  and  its 
subclassification of course of the disease, and by the meticulous clinical exclusion of 
other  articular  diseases.  There  is  often  no  one  pathognomonic  finding  for  these 
disorders. The classic intermittent fever in association with the typical rash and objective 
arthritis is highly suggestive of systemic-onset JRA. The diagnosis is based on a history 
compatible with inflammatory joint disease and a physical examination that confirms the 
presence of arthritis (see Table 154-1 ). Some children have persistent arthralgia despite 
repeated  normal  physical  examinations.  Although  they  do  not  fulfill  the  diagnostic 
criteria for JRA initially, that diagnosis may become evident as late as ≥2 yr after the 
initial  presentation.  Laboratory  abnormalities  characteristic  of  inflammation  include 
elevated  erythrocyte  sedimentation  rate  (ESR)  and  C  reactive  protein  (CRP), 
leukocytosis,  thrombocytosis,  and  the  anemia  of  chronic  disease,  which support  the 
diagnosis.
DIFFERENTIAL DIAGNOSIS 
Arthritis can be the presenting manifestation for any of the rheumatic diseases of 
childhood, including systemic lupus erythematosus (SLE) , juvenile dermatomyositis , 
sarcoidosis , and the vasculitic syndromes . In scleroderma, swelling along the digits 
early in the disease is not confined to the joints and subsequent loss of motion may occur 
without any articular  swelling.  Acute rheumatic  fever is  characterized by exquisite 
joint pain and tenderness, a remittent fever, and polyarthritis that is usually migratory. 
Autoimmune hepatitis  can be associated with an acute arthritis.  Lyme disease 
should be considered in children living in or visiting endemic areas who present with 
oligoarthritis.  Although  a  history  of  tick  exposure,  preceding  flu-like  illness  and 
subsequent rash should be sought, these are not always present. Monarticular arthritis 
unresponsive to anti-inflammatory treatment may be the result of chronic mycobacterial 
or other infection; the diagnosis is often established only by synovial biopsy. Joint pain 
and swelling of  a single  joint  suggests  trauma or  infection;  correlation with history, 
laboratory, and radiologic findings helps exclude these possibilities. 
Conditions Causing Arthritis or Extremity Pain
RHEUMATIC AND INFLAMMATORY DISEASES
  Juvenile rheumatoid arthritis
  Systemic lupus erythematosus
  Juvenile dermatomyositis
  Polyarteritis
  Vasculitis
  Scleroderma
  Sjögren syndrome
  Behçet disease
  Overlap syndromes
  Wegener granulomatosis
  Sarcoidosis
  Kawasaki syndrome
  Henoch-Schönlein purpura
SERONEGATIVE SPONDYLOARTHROPATHIES
  Juvenile ankylosing spondylitis
  Inflammatory bowel disease
  Psoriatic arthritis
  
Reactive  arthritis  associated  with  urethritis,  iridocyclitis,  and 
mucocutaneous lesions
INFECTIOUS ILLNESSES
  
Bacterial  arthritis  (septic  arthritis,  Staphylococcus  aureus, 
pneumococcus, gonococcus, H. influenzae)
  Lyme disease
  
Viral  illness  (parvovirus,  rubella,  mumps,  Epstein-Barr  virus, 
hepatitis B)
  Fungal arthritis
  Mycobacterial infection
  Spirochetal infection
  Endocarditis
REACTIVE ARTHRITIS
  Acute rheumatic fever
  
Reactive  arthritis  (post-infectious  from  Shigella,  Salmonella,  
Yersinia, Chlamydia, or meningococcus)
  Serum sickness
  Toxic synovitis of the hip
  Postimmunization
IMMUNODEFICIENCIES
  Hypogammaglobulinemia
  Immunoglobulin A deficiency
  Human immunodeficiency virus
CONGENITAL AND METABOLIC DISORDERS
  Gout
  Pseudogout
  Mucopolysaccharidoses
  Thyroid disease (hypothyroidism, hyperthyroidism)
  Hyperparathyroidism
  Vitamin C deficiency (scurvy)
  
Hereditary  connective  tissue  disease  (Marfan  syndrome,  Ehlers-
Danlos syndrome)
  Fabry disease
  Farber disease
  Amyloidosis (familial Mediterranean fever)
BONE AND CARTILAGE DISORDERS
  Trauma
  Patellofemoral syndrome
  Hypermobility syndrome
  Osteochondritis dissecans
  Avascular necrosis (including Legg-Calvé-Perthes disease)
  Hypertrophic osteoarthropathy
  Slipped capital femoral epiphysis
  Osteolysis
  Benign bone tumors (including osteoid osteoma)
  Histiocytosis
  Rickets
NEUROPATHIC DISORDERS
  Peripheral neuropathies
  Carpal tunnel syndrome
  Charcot joints
NEOPLASTIC DISORDERS
  Leukemia
  Neuroblastoma
  Lymphoma
  Bone tumors (osteosarcoma, Ewing sarcoma)
  Histiocytic syndromes
  Synovial tumors
HEMATOLOGIC DISORDERS
  Hemophilia
  Hemoglobinopathies (including sickle cell disease)
MISCELLANEOUS DISORDERS
  Pigmented villonodular synovitis
  Plant-thorn synovitis (foreign body arthritis)
  Myositis ossificans
  Eosinophilic fasciitis
  Tendinitis (overuse injury)
  Raynaud phenomenon
PAIN SYNDROMES
  Fibromyalgia
  Growing pains
  Depression (with somatization)
  Reflex sympathetic dystrophy
  Regional myofascial pain syndromes
Physical findings may suggest other diagnoses. Acute onset of a synovial effusion 
and an  inflamed joint  suggests  bacterial  infection.  Chondromalacia  of  the patella  or 
related femoropatellar syndromes can cause knee pain and instability. Tenderness over 
insertion of ligaments and tendons and lower extremity arthritis, especially in a male, 
raises  the  possibility  of  a  spondyloarthropathy.  Psoriatic  arthritis can  present  with 
limited joint involvement in an unusual distribution (e.g., small joints of the hand and 
ankle) prior to onset of cutaneous disease. Until psoriasis develops, which may only 
occur years after the arthritis, the diagnosis can only be suspected (especially with a 
positive family history). Isolated hip pain with limited motion raises the possibility of 
suppurative  arthritis  or  osteomyelitis,  Legg-Calvé-Perthes  disease,  slipped  capital 
femoral  epiphysis,  or  chondrolysis  of  the  hip  Repeated  episodes  of  joint  pain  and 
swelling,  especially  in  lower  extremity  joints,  usually  lasting  <1  wk with  complete 
resolution between episodes, can occur in juvenile episodic arthritis, often attributed to 
hypermobility. 
Inflammatory bowel disease may present with oligoarthritis,  usually affecting 
joints in the lower extremities,  and unexplained anemia.  Arthritis can also follow an 
enteric infection . Unexplained arthralgia accompanied by a fear of returning to school 
suggests school phobia as a cause for the arthralgia.
Less commonly, other diseases can produce joint symptoms and signs. Children 
with undiagnosed leukemia may have joint pain resulting from metaphyseal expansion 
of  the  malignant  infiltration  of  the  bone  marrow,  sometimes  months  before 
demonstrating  peripheral  blood  lymphoblasts.  Examination  of  such  a  child  usually 
reveals a deeper pain to palpation of the bone; bone marrow aspiration confirms the 
diagnosis. Some diseases, such as cystic fibrosis, diabetes mellitus, and the glycogen 
storage diseases have associated arthropathies (see Chapter 168 ). Swelling that extends 
beyond the joint can be a sign of lymphedema, which may rarely coexist with JRA, or 
Henoch-Schönlein purpura. A peripheral arthritis indistinguishable from JRA occurs in 
the humoral immunodeficiencies, such as common variable immunodeficiency and X-
linked  agammaglobulinemia.  Skeletal  dysplasias  associated  with  a  degenerative 
arthropathy are diagnosed by characteristic radiologic abnormalities.
LABORATORY FINDINGS
Hematologic  abnormalities  often  reflect  the  degree  of  systemic  or  articular 
inflammation,  with  elevated  white  blood  cell  and  platelet  counts  and  decreased 
hemoglobin concentration and mean corpuscular  volume. The ESR and CRP usually 
mirror these findings, along with elevated serum immunoglobulins. It is not unusual for 
the ESR to be normal in some children with chronic arthritis. Because platelets are an 
acute-phase reactant, a high ESR and neutropenia with a low platelet count may be a 
clue to leukemia as a cause of periarticular swelling and pain.
Elevated ANA titers are present in at least 40–85% of children with oligoarticular 
or  polyarticular  JRA,  but  are  unusual  in  children with systemic-onset  disease.  ANA 
seropositivity is associated with increased risk for the development of chronic uveitis in 
a child with limited joint disease. 
Rheumatoid-factor  (RF)  seropositivity  may  be  associated  with  onset  of 
polyarticular involvement in an older child (≈8%) and the development of rheumatoid 
nodules,  and with a  poor  overall  prognosis  with eventual  functional  disability.  Both 
ANA and RF seropositivity occur in association with transient events during childhood, 
such as viral infections, particularly Epstein-Barr virus. Seropositivity for both ANA and 
RF must  be  defined at  a  specific  titer  in  relation  to  accepted  positive  and negative 
controls and a laboratory-defined coefficient of variation.
Bone mineral metabolism and skeletal maturation are often abnormal in children 
with JRA with a  history  of  active synovitis,  relatively independent  of  onset  type or 
course subtype, and predominantly affect appendicular cortical bone, with less effect on 
the normal age-related development of trabecular bone. Increased levels of cytokines 
such  as  IL-6  may  decrease  bone  formation  (reflected  by  decreased  serum levels  of 
osteocalcin  and  bone-specific  alkaline  phosphatase)  to  a  greater  extent  than  bone 
resorption (which may also be decreased, as reflected by decreased levels of tartrate-
resistant acid phosphatase). Abnormalities of skeletal growth become most prominent 
during the pubertal growth spurt and in postpubertal children (Tanner stages IV–V) and 
lead to failure of the child to achieve acceptable peak bone mass (osteopenia).
Early  radiographic  changes  of  arthritis  include  soft  tissue  swelling,  regional 
osteoporosis,  and  periosteal  new-bone  apposition  about  affected  joints.  Regional 
epiphyseal closure may be stimulated, and local bone growth decreased. In large joints, 
linear  growth  may  be  accelerated  and  limb  length  discrepancy,  especially  with 
involvement of a knee, becomes prominent. 
Continued  active  disease  may  lead  to  subchondral  erosions  and  narrowing  of 
cartilage  space,  especially  in  small  tubular  bones,  with  varying  degrees  of  bony 
destruction  and,  potentially,  fusion.  Characteristic  radiographic  changes  in  cervical 
spine, most frequently in the neural arch joints at C2-3  may progress to atlantoaxial 
subluxation. MRI studies may be helpful to evaluate both joint and soft tissues and are 
more sensitive to early, minimal changes than is plain radiography.
Treatment
The aims of good management of JIA are to prevent joint destruction, promote 
growth and development and management of complications3.
Effective management of JIA needs a multidisciplinary team approach with inputs 
from a pediatric rheumatologist, who will liaise with the local general pediatrician or 
general  physician,  ophthalmologist,  nurse  specialist,  physio-therapist,  occupational 
therapist,  orthopedic surgeon,  podiatrist,  clinical  and social  worker.  The medications 
used  to  treat  JIA  are  divided  into  first-line  agents,  second-line  agents, 
immunosuppressive agents, biologicals and steroids.
First-line agents
Nonsteroidal anti-inflammatory agents:-
Nonsteroidal  anti-inflammatory  agents  (NSAIDs)  decrease  inflammation  by 
inhibiting the synthesis of prostaglandins. Half of the children whorespond to NSAIDs 
do so after 2 weeks and two thirds by a month; thus if a patient has minimal response, it  
may be advantageous to change to an NSAID of another chemical class after a month. 
All currently used drugs inhibit the activity of both cycloxygenases (COXs) I and II.  
COX-II specific NSAIDs are not yet licensed for use in children in most countries, as 
experience with these drugs are scarce4.
Ibuprofen : 30-40 mg/kg/d
Naproxen: 10-15mg/kg/d
Indomethacin: 1-3 mg/kg/d
Aspirin  : 70-100mg/kg/d
Second line agents
Disease Modifying Anti Rheumatic Drugs (DMARDs) 
1. Methotrexate: 
Of  current  therapies,  once  a  week low dose  methotrexate  has  emerged as  the 
therapeutic agent of choice for children who fail to respond to adequate administration 
of an NSAID.
Guidelines for methotrexate therapy (9) :
1. before starting therapy a baseline investigations like blood counts,  ESR, 
CRP, liver & renal function tests, chest x ray should be done.
2. coadminister folinic acid 1 mg daily
3. monitor liver enzymes and blood counts 
2. sulfasalazine  
3. Hydroxychloroquine 
Immunosuppressives 
Corticosteroids
The use of corticosteroids in JIA falls into the following four categories Intra-
articular: In children with oligoarticular disease and involvement of one or two joints, 
injection of the affected joints can lead to longterm remission in 50% of the patients so 
treated. In children with polyarticular joint involvement or systemic onset disease with 
multiple  joint  involvements,  injection  can  be  used  if  one  joint  is  swollen  out  of 
proportion  to the others or if the child is developing a flexion contracture around the 
joint.  Corticosteroid  injections  can  prevent  and  reverse  the  development  of  flexion 
contractures and decrease the development of limb length discrepancies in children who 
have  knee  involvement.  The  molecule  available  to  us  istriamcinolone  acetonide. 
Triamcinolone hexacetonide is the preferred drug but is not available in India
Dose: -  The dosage regime for triamcinolone hexacetonide currently used is 1 
mg/kg for  large joints  (knees,  hips,  and shoulders)  and 0.5 mg/kg for  smaller  joints 
(ankles, wrists, and elbows). For the hands and feet, 1–2 mg/joint for MCPs/MTPs, and 
0.6–1 mg/joint for PIPs may be used. If triamcinolone acetonide is being used, doses are 
doubled6.
Topical  Steroids:  Topical corticosteroids preparations are used in children who 
have uveitis.
Oral: Rarely, patients with severe systemic or polyarticular disease may require 
long-term oral corticosteroid use, but efforts must be made to keep the dose as low as 
possible. The inability to taper corticosteroid therapy is an indication to start second-line 
therapy and/or immuno-suppressive medications.
Intravenous steroid “pulse” therapy: Methylprednisolone given intravenously over 
one hour, can be useful in select children with systemic onset disease to treat severe 
systemic symptoms and minimize daily steroid dosing 
Recent arrivals in JIA management (Role of biologicals):-
Tumor  necrosis  factor  (TNF-Alpha)  inhibitors: 
-Etanercept,Infliximab,Adalivumab etc
Interleukin 1 antagonists: -Anakinra
Others: - Anti-CD 20 agent rituximab, CTLA-4
Ig abatacept, anti-IL6 tocilizumab, Anti-CD22 and anti-lymphostat B7.
TNF Antagonists: -(Etanercept and infliximab)
Action: - Etanercept binds to TNF alpha and
prevents binding to cellular receptors while
Autologous stem cell therapy
Rationale for therapy: 
There is substantial evidence that abnormal auto reactive T cell clones have an 
important role in the pathogenesis of JIA.Massive immunosuppression to suppress these 
clones  may  induce  disease  remission.  Bone  marrow  reconstitution  with  non-auto 
reactive
T cell precursors would produce a normal T cell repertoire without memory T 
cells(11).
Physiotherapy and Occupational Therapy
Therapists  are  critical  to  restore  function  and  strength  of  affected  joints  and 
musculature. They plan a treatment program that incorporates exercises, stretches for the 
joints, and activities of daily living. The occupational therapist provides custom made 
splints to maintain hand function,  joint position,  and assist  children whose disability 
requires modification of the environment. Physiotherapy provides pain relief, in addition 
to improving  joint range and muscle strength. Finally therapist is usually the key person 
to educate the parents, and school personnel to ensure integration of therapy goals into 
the child’s daily routine.
Specific therapy (14), (15)
Step 1 Step 2 Step 3 Step 4
Oligoarticular NSAID
(2-4wks)
Change 
NSAID
Intra articular
(1-2 jts)
Sulphasalazine
(3-4/extended)
Methotrexate, HCQ
Polyarticular NSAID
2-4wks
Change 
NSAID
Methotrexate/
DMARD
Steroids, 
immunossuppresives
Systemic Pulse/oral 
steroids
NSAID
Change 
NSAID
Oral steroids
Complications of JIA
The major systemic complications of JIA are
1. Uveitis - majority occurs in oligoarticular type. The greatest risk of uveitis 
occurs within the first 2 yrs after the onset of JIA and the risk declines by 8 yrs 
after arthritis onset (12)
2. Macrophage activation syndrome
3. Growth retardation
4. Amyloidosis
Prognosis
Bad Prognostic factors in JIA (13)
SOJIA  :   Oligoarthritis,Polyarthritis,Psoriatic  patients,  ERA  ,  Fever,  Polyarticular 
involvement,  a  high  initial  dose  steroid  requirement,  steroid  dependence  and 
thrombocytosis at the end of 6 months.
Oligoarthritis : Severity of arthritis within the first 2 years
Polyarthritis : Positive rheumatoid factor
REVIEW OF LITERATURE
1. D  Sircar  et  al  studied  the  clinical  manifestation,  severity  and  immunological 
features of JIA and its influence on growth and cardiac involvement. Sample size 
was  50.  Results  :28%  were  oligoarticular,  22%systemic  onset,  18%  post 
streptococcal  reactive arthritis,  10% rheumatoid factor  + ve,  20%   rheumatoid 
factor  –ve,  female  predominance  in  polyarticulartype,  male   predominance  in 
oligoarticular and systemic onset type, 65 had uveitis.  Indian Paediatrics 2006
2. Gurkirpal  singh  et  al  adapted  the  Stanford  health  assessment  questionnaire  in 
children  with JIA to measure the health and functional status. Sample size was 
72. Results : 9 patients were inactive, 32 had mild disability, 24 moderate , 7 had 
severe  disability.  Study  concluded  that  Childhood  Health  Assessment 
Questionnaire  is  a  valid,  reliable  and  sensitive  instrument  for  measuring 
functional status in children with JIA. Arthritis and Rheumatism 1994 
3. Oen K et al studied the predictors of disability. Patients were selected if they were 
> or < 8 yers, onset of arthritis < 5 yrs or > 5 yrs . results : male sex correlated 
with worse outcome in systemic onset JIA, but less disability in rheumatoid factor 
+ve  polyarticular  JIA.  Younger  age  at  onset  predicted  longer  active  disease 
duration in oligoarticular and rheumatoid factor –ve  polyarticular  JIA and shorter 
active  disease  duration  in  systemic  onset.variables  predictive  of  long  term 
outcome are specific for each type the most important predictors were age at onset 
and sex. J Rheumatol 2003,mar;30(3):585-93
4. Amita agarwal et al studied the outcome in JIA in India. Indian pediatrics 2004. 
There were 214 children in study.76 oligo, 93 polyarticular, 45 systemic  with 135 
of them boys.  At last  follow up 128 had active disease,  58 stable  disease,  28 
inactive.  polyarticular  had  the  worst  outcome  with  only  3  out  of  93  having 
inactive disease, 13/76 in oligoarticular, 12/45 in systemic onset.
5. L M A Jansen  a  , D van Schaardenburg  a  , I E van der Horst-Bruinsma  b  , Ann Rheum 
Dis 2000;59:223-226  
To find disease parameters that can predict the functional capacity of patients with 
early rheumatoid arthritis (RA) at the first visit to the rheumatologist and one year after 
entry. 
METHODS Patients referred to the outpatients clinic between 1995 and 1996, 
with  a  symptom  duration  of  less  than  three  years  and  fulfilling  the  American 
Rheumatism Association 1987 revised criteria for RA within one year after entry were 
included. Assessments of the duration of morning stiffness, the Disease Activity Score 
(DAS: a composite score based on erythrocyte sedimentation rate (ESR), number of 
painful and swollen joints and patient global assessment), pain (Visual Analogue Scale), 
and the Assessment Questionnaire (HAQ) were performed every three months. 
RESULTS 133  patients  were  included  in  the  study.  The  median  duration  of 
complaints was three months (range 0–35) and the median HAQ score at entry was 1.12 
(range 0–3). There was no correlation between duration of complaints and the HAQ at 
entry (r = 0.01). An HAQ score under the 50th percentile at entry could be predicted 
correctly for 74% of the patients by entry DAS and C reactive protein concentration, and 
at one year could be predicted correctly for 73% of the patients by entry HAQ and pain 
score. 
CONCLUSION Disease activity is strongly correlated with a lower functional 
capacity at entry, whereas disease duration is not. The functional status at entry is a good 
predictor for functional status at one year
Objective. Inflammatory  arthritis  in  childhood  is  variable  in terms  of   both 
presentation  and  outcome.  This  analysis  describes disease  activity  in  children  with 
juvenile  idiopathic  arthritis (JIA)  during  the  first  year  following  presentation  to  a 
paediatric rheumatologist  and  identifies  predictors  of  moderate  to  severe  disability 
[defined using a Childhood 
HAQ (CHAQ) score >0.75] at 1 year.
Methods Demographics, disease features, joint count, CHAQ, physician's global 
assessment, parent's  general  evaluation  of  well-being (PGE),  ESR and treatment, are 
collected  at  first  presentation,  6  months  and  then  yearly.  Independent  predictors  of 
CHAQ >0.75 at 1 year in children diagnosed with JIA were identified
Results. Seven hundred and forty children with JIA were included; median age at 
presentation 7.6 years, 64% girls. During the first year, 85% received NSAIDs, 70% IA 
corticosteroids, 47% MTX and 27% systemic steroids (oral or i.v.). Median presenting 
CHAQ score was 0.63 and decreased to 0.25 at 1 year; 32% had  CHAQ >0.75 at 1 year. 
The strongest  predictor  of CHAQ >0.75 at 1 year was CHAQ >0.75 at  presentation 
(odds ratio 3.92;  95% CI 2.17,  7.09).   Additional  predictors  included female gender 
Conclusion. Although CHAQ score improved in most children, the strongest predictor 
of persistent disability at 1 year was moderate to severe disability at first presentation. 
Follow-up beyond 1 year will assess whether CHAQ at presentation will continue to be a 
predictor of future poor outcome.
6. Surjit singh et al , clinical an immunological profile, Indian pediatrics 1999
Objective: To  study  the  clinical  and  immunological  profile  of  children  with 
juvenile rheumatoid arthritis (JRA). Design: Retrospective hospital based study. Setting: 
Tertiary  level  center  of  North  India.  Subjects:  74  patients  attending  the  Pediatric 
Rheumatology and Immunology Clinic over last 5 years. 
Results: The patients were aged between  9  months to/2  years with malefemale 
ratio  of  1.8:1.  Eleven  (14.9%)  patients  had  systemic  onset  JRA,  28  (37.8%)  had 
polyarticular onset type and 35(47.3%) had pauciarticular onset type JRA. Uveitis was 
present only in one patient and rheumatoid nodules were present in  4(5.4%)  patients. 
Rheumatoidfactor was positive in 2(2.7%) and antinuclear antibody was present in one 
patient only. RIA-B27 was positive in 4 children. Two patients developed amyloidosis. 
Conclusion: The clinico-immunological profile of JRA at Chandigarh appears to 
be somewhat different from that reported from other centers in India.
7. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing 
early predictors and outcomeBerit FlatØ,  Anna Smerdel, Center for Rheumatic 
Diseases, Rikshospitalet University Hospital, Oslo, Norway. 
Objective: To describe the physical and psychosocial outcome in patients with 
juvenile  rheumatoid  arthritis  (JRA),  compared  with         subjects  in  the  general 
population,  Predictors of persistent disease        and joint erosions were: young onset  
age and large numbers of affected          joints, long duration of elevated erythrocyte 
sedimentation rate (ESR),        and positive IgM rheumatoid factor (RF) within the first 6 
months. 
Additionally, persistent disease was predicted by the presence of DRB1*08, and 
joint erosions were predicted by symmetric arthritis  and DRB1*08 and HLA-B27 in 
combination. DRB1*01 was a predictor of joint erosions in the pauciarticular onset type 
(n = 163). Predictors of physical disability were: female sex, symmetric arthritis, hip 
joint involvement, long duration of elevated ESR and IgM RF. 
Conclusion:  Compared with healthy  controls,  patients  with JRA had impaired 
physical  health  and  lower  employment  rates  after  more  than  11  years  of  disease 
duration. Elevated ESR, extensive and symmetric arthritis, positive IgM RF, DRB1*08, 
DRB1*01, HLA-B27 and DRB1*08 in combination, early onset, and female sex were 
early risk factors for an unfavorable outcome. 
STUDY JUSTIFICATION
Though  Juvenile idiopathic arthritis is not a rare disease its true incidence and 
prevalence  are  not  available.  It  is  a  disease  of  variation  in  terms   presentation  and 
outcome. Comparison with other studies is difficult due to variation in classification, 
presentation and changing treatment. Our hospital also lacks such study. 
AIM
To study the clinical and laboratory profile in children < 12 years with juvenile 
idiopathic arthritis and to assess their health and functional status for a period of one 
year
METHODOLOGY
STUDY DESIGN : Descriptive study
PLACE : Rheumatology OP and general ward, Institute of Child Health
STUDY POPULATION : Children < 12 years with juvenile idiopathic arthritis
STUDY PERIOD : 2 years 
INCLUSION CRITERIA : all diagnosed cases of juvenile idiopathic arthritis based on 
International League of Associations  for Rheumatology (ILAR) criteria
EXCLUSION CRITERIA :children  with  juvenile  idiopathic  arthritis  associated  with 
other chronic illness
MANUOEVERE :   All  children under inclusion criteria  are recruited from OP and 
ward. They are grouped into types based on ILARcriteria .They are investigated and 
assessed for functional status based on Childhood Health Assessment Questionnaire and 
Disease Activity Score 28. They are followed up for one year and re-assessed for their 
functional status 
STATISTICAL ANALYSIS
The statistical method applied were using the patients characteristics, symptom 
profile, lab profile, scoring systems and each were matched against degree of disability. 
Datas  were  entered  in  Microsoft  excel  sheet  and  analysed  using  SPSS  ver  11  for 
windows , Epi info ,  and chi square and p values were obtained
OBSERVATION
Type No. %
Oligo 8 14.8
Poly 16 29.6
Systemic onset 30 55.6
0
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Total no. of patients were 54. Out of which 8 (14.8%) were of oligo-articular type, 
16 (29.6%) were polyarticular type and 30 (55.6%) were systemic onset.
Age No. %
< 8 yrs 30 55.6
>8 yrs 24 44.4
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Out  of 54 children, 30 (55.6%) were of  <8 yrs and 24 (44.4%) were of  age > 8 
yrs .mean   age was 7.83 yrs.
sex No. %
Male 28 51.9
Female 26 48.1
Out of 54 children , 28 (51.9%) were males and 26 (48%) were females.
Onset No. %
< 5 yrs 30 55.6
>5yrs 24 44.4
Out of 54 children, 30 (55.6%) had disease onset less than 5 yrs duration  whereas 
24 (44.4%) had onset more than 5ys
Symptoms No. %
Fever 46 85.2
Rash 11 20.4
Hepatomegaly 20 37
Joint pain 54 100
Joint swelling 17 31.5
Lymphadenopathy 16 29
Pericarditis 0 0
Uveitis 0 0
0
10
20
30
40
50
60
70
80
90
100
No. % 
Fever 
Rash 
Hepatomegaly 
Joint pain 
Joint swelling 
Lymphadenopathy 
Pericarditis 
Uveitis 
Among  clinical features, fever was present in 46 (85.2%) children, 11 (20.4%) 
had  rashes,  20(37%)  had  hepatomegaly,  joint  pain  and  swelling  was  present  in  54 
(100%) and 17 (31.5%) children respectively, 16 of them had lymphadenopathy. 
None  had involvement of heart and eyes.  
Joint involvement No. %
Cervical 4 7.4
Shoulder 3 5.6
Elbow 23 42.6
Wrist 40 74.6
Metacarpo-phalangeal 28 51.9
Proximal interphalangeal 16 29.6
Hip 1 1.9
Knee 48 88.9
Ankle 38 70.4
Metatarsophalangeal 12 22.2
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Almost every joint was involved in study population. Knee is the commonest joint 
involved. 40 cases (74.6%) had wrist involvement. Ankle involvement was found in 38 
(70.4%) cases.23 (42.6%) children had involvement of elbow. There was evidence of 
small  joint  involvement,  metacarpophalangeal  -28  (51.9%),  prox  interphalangeal 
-16(29.6%), metatarsophalangeal-12(22.2%) children. Hip, shoulder and cervical joint 
involvement were also seen in few cases.
Articular presentation No. %
Symmetrical 33 61.1
Asymmetrical 21 38.8
33  (61.1%)  out  of  54  children  had  symmetrical  joint  involvement  and  the 
remaining 21(38.8%) had asymmetrical involvement of joints. 
Hematological parameters No. %
Total count > 11000 27 50
Anemia <10g/dl 25 46.3
ESR >20mm in 1st hour 42 77.8
Rheumatoid factor +ve 10 18.5
ASO +ve 12 22.2
CRP+ ve 32 59.3
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Out of 54 children, 50% had leucocytosis, anemia was present in nearly 50% of 
cases.ESR was elevated in 42 (77%) cases. Rheumatoid factor was positive in 10 cases. 
CRP was positive in two-thirds of cases and ASO was positive in 12 (22%) children. 
Treatment No. %
NSAIDS 54 100
Prednisolone 34 63
Methotrexate 46 85.2
All children received analgesics. Few children 34(63%)  were started on short 
course steroids in view of disease activity . Subcutaneous methotrexate wasgiven in 46 
(85.2%) children.
Measurement of functional status : – 
1.CHILDHOOD HEALTH ASSESSMENT QUESTIONAIRE
HAQ – 1(first visit) No. %
Inactive 4 7.4
Mild 21 38.9
Moderate 15 27.8
Severe 5 9.3
No. %
Inactive
Mild 
Moderate 
Severe 
Children  were  assessed  for  their  functional  status  using  health  assessment 
questionnaire  in  their  initial  visit  and were  graded accordingly.The mean  score  was 
1.03 .   4  children  did  not  have  disability,  21  had  mild  disability,  15  had  moderate 
disability and 5 cases had severe disability. 9 patients were  not applicable  as they were 
below 3 yrs.
HAQ -2 (after 1 yr) No. %
Inactive 10 18.5
Mild 21 38.9
Moderate 14 25.9
Severe 0 0
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After a period of 1 yr none had severe disability. 10 cases were found to be free of 
disability, 21 – mild, 14 – moderate. The mean score was 0.89
2. DISEASE ACTIVITY INDEX 28
DAS28 – 1 (first visit) No. %
Mild 32 59.3
Moderate 19 35.2
Severe 3 5.6
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Out of 54 children, 32 (59%) had mild disease activity, 19 had moderate activity 
and 3 severe disease activity. The mean score was 2.85
DAS28 – 2(after 1 yr) No. %
Mild 45 83.3
Moderate 9 16.7
Severe 0 0
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After a period of 1 yr, none of the children had severe disease activity. 45 (83%) 
had mild activity and 9 (16%) cases had moderate disease activity. The mean score was 
found to be 2.76 . 
Oligoarticular Polyarticular Systemic 
onset
P value
Age  < 8 yrs 3 7 20
o.177
 >8 yrs 5 9 10
Out of 30 cases who were < 8 yrs, 3 were of oligoarticular, 7 polyarticular, 20 systemic onset.  
Among those who were > 8 yrs, 5 were oligoarticular, 9 polyarticular, 10 systemic onset. There was no 
statistical significance 
Oligoarticular Polyarticular
Systemic 
onset
P value
Male 6 9 13
0.258
Female 2 7 17
Among 28 males, 6 were oligoarticular, 9 polyarticular, 13 systemic onset. Among 
26 females,  2  were  oligoarticular,  7  polyarticular,  17  systemic  onset.  There  was  no 
statistical significance . 
Oligoarticular Polyarticular Systemic 
onset
P value
Disease onset 
<5yrs
3 8 19
0.369
    >5yrs 5 8 11
Children with early onset, 3 were oligoarticular, 8 polyarticular, 19 systemic onset. Those with 
late  onset,  5  were oligoarticular  ,  8 polyarticular,  11 systemic onset  type.  There was no statistical  
significance.  
Oligoarticula
r Polyarticular
Systemic 
onset p  value
Fever 5 12 29 0.021 S
Rash 0 1 10 0.028 S
Hepatomegaly 0 2 18 0.000 S
Joint pain 8 16 30
Joint swelling 0 8 9 0.044 S
Lymphadenopathy 0 2 13 0.01 S
Fever was present in 5 cases of oligoarticular, 12 cases of polyarticular, 29 cases 
of systemic onset.  P value was 0.021 which is significant Rash was not a feature in 
oligoarticular type. It was seen in 1 case of polyarticular, 10 cases of systemic  type . p 
value was 0.028 which was statistically significant.
Hepatomegaly  was seen in 2 cases of polyarticular, 18 cases of systemic type. It 
was  not  present  in  oligoarticular  type.  P  value  was  0.00  which  is  statistically 
significant. 
Joint pain was seen in 16 cases of plyarticular , 30 cases of systemic onset 8 cases 
of oligoarticular. 
Joint swelling was present in 8 cases of polyarticular, 9 cases of systemic onset. P 
value was 0.044 which is statistically significant. 
Lymphadenopathy was present 2 cases of polyarticular and 13 cases of systemic 
onset type. It was not seen in oligoarticular type. P value was 0.01 which is statistically 
significant
Oligoarticular Polyarticular Systemic 
onset
P value
Shoulder 0 1 2 0.757
Elbow 2 8 13 0.502
Wrist 3 13 24 0.038 S
Metacarpophalangeal 0 10 17 0.01 S
Prox interphalangeal 0 4 12 0.079
Hip 0 0 1 0.665
Knee 8 13 27 0.371
ankle 4 13 21 0.286
metatarsophalangeal 0 8 4 0.005 S
Shoulder jt was involved in 1 case of polyarticular, 2 cases of systemic with no 
statistical significance. 
Elbow was involved in 2 cases of oligoarticular, 8 cases of polyarticular, 13 cases 
of systemic type with no statistical significance.
Wrist is involved in 3 cases of oligoarticular,13 cases of polyarticular, 24 cases of 
systemic onset with significant p value of 0.038
Metacarpophalangeal jt was involved in 10 cases of polyarticular, 17 cases of 
systemic type. P value was significant 0.01
Proximal interphalangeal jt was involved in 4 cases of polyarticular, 12 cases of 
systemic type with no statistical significance
Hip was involved in only 1 case of systemic type.
Knee was involved in 8 cases of oligoarticular, 13 cases of polyarticular, 27 cases 
of systemic type with no statistical significance.
Ankle was involved in4 cases of oligoartiarticular, 13 cases of polyarticular, 21 
case of systemic type with no statistical significance
Metatarsophalangeal  jt  was  involved  in  8  cases  of  polyarticular,  4  cases  of 
systemic type. P value was significant 0.005
Oligoarticular Polyarticular Systemic 
onset
P value
Leucocytosis 0 6 16 0.02 S
Anemia 3 7 15 0.796
ESR 2 11 24 0.01 S
Rheumatoid 
factor + ve
0 5 5 0.165
ASO + ve 2 3 7 0.919
CRP + ve 4 6 22 0.053
Leucocytosis  was seen in  6 cases  of  polyarticular,  16 cases  of  systemic  type 
which was statistically significant (p 0.02)
Anemia  was  present  in  3  cases  of  oligoarticular,  7  cases  of  polyarticular,  15 
systemic type with no significance.
ESR was elevated in 2 cases of oligoarticular,11 cases of polyarticular, 24 cases 
of systemic type with statistical significance p 0.01
Rheumatoid factor was positive in 5 cases of polyarticular  and systemic onset 
type each.  It  was negative in  all  cases of  oligoarticular  type .  there  is  no statistical 
significance.
ASO was positive in 2 cases of oligoarticular ,3 cases of polyarticular, 7 cases of 
systemic type with no significance.
CRP was positive in 4 cases of oligiarticular, 6 cases of plyarticular, 22 cases of systemic type 
with no statistical significance
Oligoarticula
r
Polyarticular Systemic 
onset
P value
NSAIDS 8 16 30 -
Prednisolone 2 8 22 .031 S
Methotrexate 5 14 27 0.144
NSAIDS were used in all cases of oligo, poly and ststemic type.
Prednisolone  was given in 2 cases of oligoarticular, 8 cases of polyarticular,22 
cases of systemic onset type. P value was significant 0.031
Methotrexate  was  given in  5 cases  of  oligoarticular,  14 cases  of  polyarticular,  27 cases  of 
systemic type with no significance
HAQ - 1
P value
Inactive Mild Moderate Severe
Oligoarticular 2 3 1 0
o.097Polyarticular 2 8 3 0
Systemic 
onset
0 10 11 5
In oligoartiarticular type , 3 cases had mild disability, 1 had moderate disability, 2 
were free of disability.
 In polyarticular  type,  8 had mild disability3 had moderate disability, 2 had no 
disability.
 In  systemic  type 10 had mild  disability  ,  11 moderate  disability  5 had severe 
disability P value was not significant 
HAQ – 2
P value
Inactive Mild Moderate Severe
Oligoarticular 2 3 1 0
o.077Polyarticular 6 6 1 0
Systemic 
onset
2 12 12 0
After 1 yr in oligoarticular type, there was no change in disabilty status
In polyarticular type,only 1 case had moderate disability. 6 had mild disability 
remaining 6 had no disability.
 In systemic type, none had severe disability as before. 12 had mild and moderate 
disability each, 2 were free of disability.
 There is no statistical significance
DAS28 - 1
P value
Mild Moderate severe
Oligoarticular 8 0 0
0.064Polyarticular 10 6 0
Systemic 
onset 
14 13 3
All cases of oligoarticular type had mild disease activity.
In polyarticular type ,10 had mild disease activity, 6 had moderate disease activity. 
In systemic type,  14 had mild disease activity,  13 moderate and 3 had severe 
disease activity.
 There was no statistical significance 
                                   DAS28 – 2
P value
Mild Moderate severe
Oligoarticular 8 0 0 0.082
Polyarticular 15 1 0
Systemic 
onset 
22 8 0
After 1 yr , there was no change in disability status in oligoarticular group
In polyarticular type, only 1 case had moderate disease activity and remaining 15 
had mild disease activity.
 In systemic type, none had severe disability as before, 8 had moderate and 22 
cases had mild disease activity.
There was no statistical significance.  
HAQ – 1
P value
Inactive Mild Moderate Severe
Age
<8yrs
2 9 7 3
0.91
>8yrs 2 12 8 2
Among children < 8yrs, 2 had no disability, 9 had mild, 7 moderate qnd 3 had 
severe disability.
Those > 8yrs, 2 had no disability, 12 mild, 8 moderate and 2 severe disability. 
There is no statistical  significance.
HAQ – 2
P value
Inactive Mild Moderate Severe
Age
<8yrs
4 7 10 0
0.07
     >8yrs 6 14 4 0
After 1 yr, children < 8yrs, 4 had no disability, 7 had mild disability, 10 moderate disability.  
Those > 8yrs  ,6 were free of disability, 14 mild, 4 moderate. None  had severe disability. There was no 
statistical significance.
                                           HAQ – 1
P value
Inactive Mild Moderate Severe
      Male 2 14 4 3
0.12
female 2 7 11 2
Among males,  2  had no disability,  14 had mild  disability,  4  moderate,  3  severe  disability.  
Among females,  2  had no disability,  7  mild,  11 moderate,  2  with severe  disability.  There was no 
statistical significance.  
HAQ – 2
P value
Inactive Mild Moderate Severe
Male 4 11 8 0 0.70
female 8 10 6 0
After 1 yr, among males 4had no disability, 11 mild, 8 moderate disability. 
Among females,  8 had no disability,  10 mild,  6 with moderate  disability.  None had severe 
disability. There was no statistical significance.
                                           HAQ – 1
P value
Inactive Mild Moderate Severe
Disease 
onset 5yrs
2 9 8 2
0.91
>5yrs 2 12 7 3
Among those with early onset , 2 had no disability,9 mild, 8 moderate, 2 with severe disability. 
In late onset , 2 had no disability, 12 mild, 7 moderate, 3 with severe disability. There is no statistical 
significance.
                                           HAQ – 2
P value
Inactive Mild Moderate Severe
Disease 
onset
< 5yrs
5 9 7 O
0.89
>5yrs 5 12 7 0
After 1 yr, none had severe disability. In those with early onset, 5 had no disability, 9 mild, 7 
moderate. In those with late onset  , 5 had no disability, 12 mild, 7 moderate disability . there is no 
statistical significance. 
DAS28 – 1
P value
Mild Moderate severe
Age
< 8yrs
18 10 2
0.89
>8yrs 14 9 1
Among those < 8yrs , 18 had mild disease activity, 10 moderate, 2 severe disease activity. In 
those > 8yrs , 14 had mild disease activity, 9 moderate, 1 severe disease activity. There is no statistical 
significance
                                   DAS28 – 2
P value
Mild Moderate Severe
Age < 8yrs 24 6 0
0.46
>8yrs 21 3 0
After 1 yr in < 8yrs , 24 had mild and 6 had moderate disease activity. 
In the other group, 21 had mild and3 had moderate disease activity. None  had severe disease 
activity. There is no statistical significance
                                   DAS28 - 1
P value
Mild Moderate severe
Male 16 10 2
0.85
Female 16 9 1
Among males, 16 had mild disease activity, 10 moderate , 2 severe . among females, 16 had 
mild disease activity, 9 moderate, 1 severe. There is no statistical significance.
DAS28 – 2
P value
Mild Moderate severe
Male 22 6 0
0.33
Female 23 3 0
After 1 yr  none had severe disease activity.  In males,  22 had mild 6 had moderate disease 
activity. Among females, 23 had mild disease activity, 3 had moderate activity. There is no statistical  
signficance
                                   DAS28 – 1
P value
Mild Moderate severe
Disease onset
< 5yrs
8 12 0
0.122
> 5yrs 14 7 3
Among those with early onset , 8 had mild activity, 12 moderate, none had severe 
disease activity. In the other group, 14 had mild, 7 moderate 3 severe disease activity. 
There is no statistical significance
DAS28 – 2
P value
Mild Moderate severe
Disease onset
< 5yrs
26 4 0
0.46
> 5yrs 19 5 0
After 1 yr, none had severe disease activity. In those with early onset , 26 had mild 
activity and 4 had moderate disease activity. In the other group 19 had mild and5 had 
moderate activity. There is no statistical significance. 
DISCUSSION
In our study, there were 54 patients in last 2 yrs. The commonest type of arthritis 
studied in our hospital was systemic onset followed by polyarticular. This is in contrast 
to previous studies done (16) (18) where oligoarticular was the commonest type. 
The  mean  age  of  patients  was  7.83  yrs.  Most  of  the  children  were  affected 
between 9 to 11 yrs. Though previous studies (2) state that there will be a peak period of 
onset , the age incidence in this study is not concurrent with that which may be because 
of smaller group of study. 
In this study males slightly outnumber females. Males 51.95, females 48.1%. this 
is concurrent with two Indian studies by gurkirpal singh et al (17) and surjit singh et al 
(16).  Male  :  female  ratio  were  6:2  in  oligoarticular,  9:7  in  polyarticular,  13:17  in 
systemic type.
Fever and joint pain were the predominant symptoms in all cases studied  which is 
in accordance with previous studies in india (16) (19)  and abroad (2) (3) . rash was 
typically  encountered  in  systemic  onset  type  which  is  comparable  with  previous 
studies(8).  Hepatomegaly was also associated feature in systemic onset type .  this is 
comparable with studies in india (16)  pericarditis and uveitis were not associated with 
any of the cases studied. This is in contrast to studies in india (16) (18) and abroad  (2) 
(8). This could be due to smaller group in our study and poor representation of cases – 
only 8 cases of oligoarticular type. 
Among  the  joint  involvement,  knee  and  wrist  were  predominantly  involved. 
Wrist,  metacarpophalangeal,  and  metatarsophalangeal  joints  were  characteristically 
involved in polyarticular and systemic type which was statistically significant. This is 
comparable  with  previous  studies  (19)  .  Articular  involvement   was  found  to  be 
symmetrical in 6% cases and asymmetrical in 21% .
ESR was significantly elevated in majority of cases 77% it correlated with those 
who presented with disease activity and disability leucocytosis and CRP positivity was 
also  a feature in those cases with significant correlation . ASO was elevated in 22% 
cases which did not correlate. Rheumatoid factor was positivein 18.5 % cases – 9% 
inpolyarticular, 9% in systemic type. These figures are similar with previous studies (2) 
(19) . rheumatoid factor positivity is said to be associated with occurrence of rheumatoid 
nodules.  However  in  our  study  none  of  them  had  rheumatoid  nodules.  Juvenile 
idiopathic arthritis being a chronic disease , anemia was present in 46% cases . NSAIDS 
was given in all cases as they all presented with joint pain initially. Steroids were started 
in 34 cases at start of study in view of disease activity. Methotrexate was given in 46 
cases – 12 patient received subcutaneous methotrexate in view of disease activity and 
moderate to severe disability . at start of study, majority of children  were having mild to 
moderate disability and disease activity- 5 cases 9% had severe disability. This worse 
disability was common in polyarticular and systemic onset type which is comparable 
with earlier studies done by amita agarwal (20) where polyarticular had worst outcome. 
In contrast after 1 yr follow up in our study , none of them had severe disability and 12 
cases  of  systemic  type  had  moderate  disability.  5  cases  who  had  severe  disability 
initially were started on subcutaneous methotrexate and prednisolone . at the end of 1 yr 
2 children had moderate disease activity and 3 cases had mild activity . so methotrexate 
and steroids are found to be effective in controlling disease activity. 2 out 3 children 
with polyarticular type who had moderate disability, improved after starting steroids and 
had mild disabilityafter  1 yr.  out  of  11 cases with systemic type who had moderate 
disability , after starting steroids 2 were free of disability and 3 had mild disability. The 
mean HAQ score at start of study was 0.78 in oligoarticular, 1.03 in polyarticular, 1.46 
in systemic onset. After 1 yr follow up, the mean scores were 0.75 in oligoarticulr,0 .98 
in polyarticular, 1.20 in systemic type. At start of study,  children subjected to DAS28 
scoring, 3 cases with systemic type had severe disease activity who also had severe 
disability in HAQ , after starting steroids 2 cases were found to have moderate disease 
activity and 1 had mild disease activity . according to previous studies (21), strongest 
predictor  for  persistent disability was HAQ > 0.75 at  anitial  presentation.  Our mean 
score at start  of study was 1.03 and follow up score was 0.89. this is  in contrast  to 
previous  study  so  further  follow up will  be  necessary  for  future  outcome regarding 
disability status children < 8 yrs , 3 had severe disability in those > 8 yrs 2 had severe 
disability. 
This is concurrent with previous study (22). Both male female had moderate to 
severe disability initially which is in contrast to previous studies (22)
SUMMARY
Although juvenile rheumatoid arthritis is not a rare disease, its true frequency is 
not known in our country. In west, its incidence is found to be 6-8 cases /100000. 
JIA on  childhood  is  a  variable  in  terms  of  both  presentation  and  outcome. 
Comparison across studies has been difficult for many reasons, including variability in 
classification of childhood arthritis, differences in study design and changes in treatment 
over time .commonest type in our study was systemic onset  in contrast to studies in 
india  and  abroad.  Most  common  affected  age  group  is  9-11  yrs.  Males  outnumber 
females which is concurrent with other studies. Fever and joint pain are predominant 
symptoms which is comparable with previous studies. 
Uveitis  is  not  seen an any of  oligoarticular  type which is  in  contrast  to  other 
studies  which  can  be  attributed  to  smaller  study  group.  Knee  and  wrist  are  most 
commonly  involved  which  is  comparable  with  previous  studies.  ESR,  CRP  and 
leucocytosis have significant correlation with disease activity. Rheumatoid factor is seen 
in  18.5  % cases  in  accordance  with  studies  in  india  and  abroad.  NSAIDS are  the 
mainstay  of  treatment.  Methotrexate  and  steroids  are  effective  drugs  in  controlling 
disease process and activity. Majority of cases have moderate to severe disability in 
polyarticular and systemic onset type which is concurrent with previous studies with 
mean HAQ and DAS28 scores of 1.03 and 2.85 respectively.on starting steroids disease 
activity is controlled and disability improves.children with early age onset have severe 
disability. Both sexes have moderate to severe disability.
CONCLUSION
Juvenile  idiopathic  arthritis   is  the  commonest  rheumatological  disorder  of 
childhood. Although the exact incidence and prevalence figures are not available  from 
our country , the condition has been reported from a number of centres in  india. From 
these  studies  it  is  seen  that  the  disease  is  somewhat  different  from  that  of  west. 
Comparison with other studies is difficult so we need more samples and longer follow 
up. Disability  status improves on treatment with steroids. 
NSAIDS  are  the  mainstay  of  treatment.  Second  line  agents  are  the  disease 
Modifying anti  rheumatic  drugs  which are  used when  NSAIDS are  not  effective  in 
controlling the disease. Methotrexate is the most frequently used drug.
Population based studies with stringent criteria and long term follow up are the 
best for studying the natural history  and outcome but are tedious and time consuming . 
even though hospital based study esp those from tertiary care centres cannot be true 
representatives of the outcome in a population yet they provide the first  step in this 
regard.
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PROFORMA
Name 
Age 
Sex 
Address 
Height 
Weight 
Duration of disease 
Clinical features present absent
• Morning stiffness
• Fatiguability
• Joint pain
• Joint swelling
• Limitation of movements
• Type of joint
         Elbow
         Wrist 
          MCP
          PIP
          Hip
          Knee
         Ankle
         MTP
• Fever 
• Hepatosplenomegaly
• Lymphadenopathy 
• Rashes 
INVESTIGATIONS 
Hemoglobin ,
 Total count
ESR
ASO, CRP
Rheumatoid factor
Liver function test
ECHO
Ophthalmic examination
JOINT COUNT 
 
LEFT RIGHT
SWOLLEN     TENDER SWOLLEN      TENDER
Shoulder
Elbow 
Wrist 
MCP
PIP
Knee 
TOTAL  
               Swollen 
               Tender 
ENTER  CLINICAL DATA TO  CALCULATE  THE  DISEASE  ACTIVITY SCORE 
(DAS28)
CLINICAL 
VARIABLE
VALUE
Tender joint count
Swollen joint count
ESR
Visual analogue scale
   
This is a programmed software. On entering the values, scores are displayed 
Interpretation 
                   
Low disease activity <3.2
Moderate    3.2 – 5.1
Severe > 5.1
 
Childhood health assessment questionnaire 
                                       
inactive mild moderat
e
severe Not 
applicable
Dressing and grooming 
Is your child able to:
Dress ? 
Apply shampoo ?
Remove socks? 
Cut nails?
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
Arising 
Stand up from floor?
Get in and out of bed ?
 
-------
-------
 
-------
-------
 
-------
-------
 
-------
-------
Eating 
Mix food ?
Lift glass to mouth ?
Open  a box ?
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
Walking 
Walk outdoors on flat 
ground ?
Climb up five steps ?
 
-------
-------
 
-------
-------
 
-------
-------
 
-------
-------
Hygiene 
Wash and dry entire body ?
Get on and off toilet?
Brush teeth ? 
Comb hair ? 
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
Reach 
Reach and get down a heavy 
object ?
Bend down to pick things?
Pull on a sweater over 
his/her head ?
Turn neck to look back ?
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
Grip 
Write with pencil ?
Open door/window ?
Turn faucets on and off ?
Push open door by turning 
door knob ?
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
Activities 
Run ? 
Get in and out of bus ?
Ride bi/tricycle ?
wash dishes/clean rooms ?
run and play ?
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
-------
 
CHAQ score assesse functions in  8 areas – dressing,  arising,  eating,  walking, 
hygiene, reach, grip, activities. Each question is scored from 0 to 3 .the question with the 
highest score determines the score for that area. The scores for each of the 8 functional 
areas are averaged to calculate the disability index.  
